You Are Leaving Avistone's Website

You have selected a link that will take you to a site maintained by a third party. Avistone provides this link as a service to website visitors. Avistone is not responsible for the privacy policy of any third party websites. We encourage you to read the privacy policy of every website you visit. Click 'Cancel' to return to Avistone's site or 'Continue' to proceed.

SCIENCE & INNOVATION

SCIENCE & INNOVATION

A Study to Investigate ANS03 in Participants With Locally Advanced or Metastatic Solid Tumors

Time:2025-06-11

Drugs: ANS03

 

NCT Number:

NCT06716138

 

Source:

https://clinicaltrials.gov/study/NCT06716138?term=NCT06716138&rank=1